Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
V&Co Co. Ltd. is currently addressing 1 pending office action. This matter is handled by a distinct examiner, DABKOWSKI, ERINNE R, who is also designated as the busiest examiner with 1 pending office action. The data shows 0 distinct art units associated with this portfolio, indicating a very narrow or specialized administrative footprint for the company's current filings.
With only a single pending office action in the system, the company's immediate prosecution strategy is tied entirely to the findings of a single examiner. This allows for a concentrated response effort focused on the specific requirements of DABKOWSKI, ERINNE R. The absence of 0 art units suggests that the applicant can focus all resources on this individual examiner's review process without navigating broader departmental standards.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DABKOWSKI, ERINNE R | 1 | 55.7% | +68.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686124 | IMPATIENS BALSAMINA-DERIVED ANTI-BACTERIAL PEPTIDE AND ANTI-BACTERIAL COMPOSITION CONTAINING SAME | DABKOWSKI, ERINNE R | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18686124 | IMPATIENS BALSAMINA-DERIVED ANTI-BACTERIAL PEPTIDE AND ANTI-BACTERIAL COMPOSITION CONTAINING SAME | DABKOWSKI, ERINNE R | 1654 | §112 | Final Rejection | — | Pending | Feb 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialV&Co Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Erinne R Dabkowski has the most, with 1 of V&Co Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.